Sally Ann Cryan Associate Professor

Prof. Sally-Ann Cryan is a pharmacist and is Professor of Drug Delivery & Pharmacoengineering in the School of Pharmacy & Biomolecular Sciences in the Royal College of Surgeons in Ireland. Her Drug Delivery & Advanced Materials team works with industry and clinicians to develop drug delivery and bioengineering strategies to meet unmet clinical needs. This work includes the development of specialised drug delivery platforms and tools for drug development with a particular focus on three areas: (i) delivery of biotherapeutics (ii) bioengineering of advanced medical materials and integration with medical devices and (iii) respiratory drug delivery. These drug delivery platforms are being developed for application in tuberculosis, cystic fibrosis and acute lung injury, inflammatory disease and cancer as well as in regenerative medicine. Prof. Cryan is currently Chair of the Executive Committee of the Trinity Centre for Biomedical Engineering and she is a PI in two world-leading Irish Research Centres; the Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CURAM) and SFI Advanced Materials & Bioengineering Centre (AMBER). She has >150 publications/presentations in peer-reviewed/professional journals (>3,000 citations) and has trained over 100 scientists and healthcare professional within her group.

Our research aims to deliver impact through;

o             preparation of dosage forms for pre-clinical testing of new drug treatments

o             design and commercialization of advanced drug delivery & drug-device technologies

o             development of advanced materials & processes for pharmaceutical engineering

o             provision of advanced tools for drug development including 3D in vitro models

Delivery of our research and work with external partners is facilitated by our:

• State of the art research laboratories
• Extensive expertise in drug pre-formulation, formulation of small molecule and biotech medicines, dosage form design & manufacture, pharmaceutical characterization, pharmaceutical engineering, in vitro and in vivo pre-clinical dosage form testing, 3D models of epithelial barriers & disease, advanced drug delivery technologies, drug-device combinations
• Close partnership with biomedical researches, our clinicians in clinical practice and industry.